for daily banking news and anonymous message boards, check out the new site cafebanking.com


» Sponsored ads

» Sponsored ads

» Sponsored ads


Go Back   Cafepharma Message Boards > Company Boards > Takeda
Register Members List Calendar Search Today's Posts Mark Forums Read

Reply

 
Bookmark and Share Thread Tools Rating: Thread Rating: 4 votes, 4.00 average. Display Modes
  #1  
Old 04-13-2012, 11:17 PM
Anonymous
 
Posts: n/a
Notworthy Did Yasu say...No more layoffs?

Watched the URL webcast. Thought I heard him apologize for the January RIF, and then promptly and emphatically say....That's it, NO MORE, WE'RE DONE with layoffs.

Am I hearing things?
Reply With Quote
  #2  
Old 04-14-2012, 02:43 AM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Quote:
Originally Posted by Anonymous View Post
Watched the URL webcast. Thought I heard him apologize for the January RIF, and then promptly and emphatically say....That's it, NO MORE, WE'RE DONE with layoffs.

Am I hearing things?
I listened intently and heard the same thing. If you caught that, did you also catch Frank Morich saying we need to trust the company making a reference to the next two years.

Anybody else hear that and wonder if he knows something that we don't know? Watch and listen again to his comment. It almost hints that there will be a need for trust or there will significant change in two years.
Reply With Quote
  #3  
Old 04-14-2012, 08:20 AM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Ya, seems eerily similar to the statements made after the June 2010 layoff's when at the NSM we were told "we need everyone in this room" and how we had a path to achieve greatness. How we could trust the company and that there would be no more layoffs. Then... BOOM! Another big RIF!

I swear Takeda will say anything to suck as much blood out of you until more layoffs are announced. I feel even less secure now. Maybe I'll take the advice of many on this board and do the minimum to keep my job and enjoy the extra time with my son and wife during the week.
Reply With Quote
  #4  
Old 04-14-2012, 10:40 AM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

The answer to all of this lies in the MATH at the executive (Non-VP) level. Yasu, Doug, and the Chief Financial Officer. When you buy a new house there's an equation they use to figure out how much house you can afford, it basically says your payment can be no more than X portion of your income. So here is the golden question........How many Field Sales Reps can or should X million in revenue fund?

Example:
500 Million in annual sales can sustain 1,800 Takeda Reps??
500 Million in annual sales can sustain 1,800 Ventiv/CSO Reps??
or.......
500 Million in annual sales can sustain 1,000 Takeda Reps, but we will gamble by keeping 800 more for another 2 years (Frank Morich 2 year comment) until the fire gets lit with more revenue from new products.

I think we all should agree that when 3.5 Billion is gone, and our existing products combined make up less than 1/7th of the 3.5, then something has to change.

Or for the very optimistic.....maybe it's normal to have 1,800 reps to support 500 million in total sales. 500 million is still a lot of money! Who really knows? Doug maybe, Yasu for sure, CFO likely.
Reply With Quote
  #5  
Old 04-14-2012, 11:20 AM
Anonymous
 
Posts: n/a
Banghead Re: Did Yasu say...No more layoffs?

Translated it means no more 6 figure packages
they'll just Jack up your goals and whack you
Reply With Quote
  #6  
Old 04-14-2012, 11:53 AM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Quote:
Originally Posted by Anonymous View Post
The answer to all of this lies in the MATH at the executive (Non-VP) level. Yasu, Doug, and the Chief Financial Officer. When you buy a new house there's an equation they use to figure out how much house you can afford, it basically says your payment can be no more than X portion of your income. So here is the golden question........How many Field Sales Reps can or should X million in revenue fund?

Example:
500 Million in annual sales can sustain 1,800 Takeda Reps??
500 Million in annual sales can sustain 1,800 Ventiv/CSO Reps??
or.......
500 Million in annual sales can sustain 1,000 Takeda Reps, but we will gamble by keeping 800 more for another 2 years (Frank Morich 2 year comment) until the fire gets lit with more revenue from new products.

I think we all should agree that when 3.5 Billion is gone, and our existing products combined make up less than 1/7th of the 3.5, then something has to change.

Or for the very optimistic.....maybe it's normal to have 1,800 reps to support 500 million in total sales. 500 million is still a lot of money! Who really knows? Doug maybe, Yasu for sure, CFO likely.
Sure would be nice if they would tell us the truth so we could plan our lives and stop living in fear/doubt about the future. If they said, we are investing 200 million in the next 2 years to keep an additional 800 reps to see if we can hit 1 Billion in combined sales, and if we do....there will be no layoffs if we can maintain that level. People would rally!! No trust equals no rally!
Reply With Quote
  #7  
Old 04-14-2012, 11:59 AM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Quote:
Originally Posted by Anonymous View Post
Sure would be nice if they would tell us the truth so we could plan our lives and stop living in fear/doubt about the future. If they said, we are investing 200 million in the next 2 years to keep an additional 800 reps to see if we can hit 1 Billion in combined sales, and if we do....there will be no layoffs if we can maintain that level. People would rally!! No trust equals no rally!
How could they ever regain our trust? They have shown over and over again that they can't be trusted. They will tell whatever lie best fits the moment. As long as they collect their bonuses, they don't care whether we trust them or not. Reps are expendable.
Reply With Quote
  #8  
Old 04-14-2012, 12:34 PM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

That is exactly what I heard Yasu say...no more Layoffs ever!! There is no way a comment like this should ever be made. The reason for the 2nd layoff was the "unforseen" BC Actos data that came out...what happens if another drug of ours has something come out about it...bottom line there will be more layoffs... Yasu is full of crap. Why isn't Sr. Mgt held accountable and why have they not lost any of there jobs???
Reply With Quote
  #9  
Old 04-14-2012, 01:37 PM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Quote:
Originally Posted by Anonymous View Post
That is exactly what I heard Yasu say...no more Layoffs ever!! There is no way a comment like this should ever be made. The reason for the 2nd layoff was the "unforseen" BC Actos data that came out...what happens if another drug of ours has something come out about it...bottom line there will be more layoffs... Yasu is full of crap. Why isn't Sr. Mgt held accountable and why have they not lost any of there jobs???
Because they are Senior Mgt. That's why! They are higher up the food chain, small fish get eaten. The smart people in life always get to stay, the common folk get laid off. Fact of life, face it or move on.

BTW, I'm common.... :-)
Reply With Quote
  #10  
Old 04-14-2012, 05:17 PM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

As long as folks like Doug Cole, Diane Digangi Trench and other overpaid, out of touch and underskilled folks are making decisions, nothing will ever change, except for the worse. Why do you think Rich left and started his own company?
Reply With Quote
  #11  
Old 04-16-2012, 08:03 AM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

0nly 500 million in sales? We will do close to 2 Billion without Actos in 2013. Check your math.

Example:
500 Million in annual sales can sustain 1,800 Takeda Reps??
500 Million in annual sales can sustain 1,800 Ventiv/CSO Reps??
or.......
500 Million in annual sales can sustain 1,000 Takeda Reps, but we will gamble by keeping 800 more for another 2 years (Frank Morich 2 year comment) until the fire gets lit with more revenue from new products.

I think we all should agree that when 3.5 Billion is gone, and our existing products combined make up less than 1/7th of the 3.5, then something has to change.

Or for the very optimistic.....maybe it's normal to have 1,800 reps to support 500 million in total sales. 500 million is still a lot of money! Who really knows? Doug maybe, Yasu for sure, CFO likely.
Reply With Quote
  #12  
Old 04-16-2012, 09:06 AM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Yasu is a very smart man. Doug should be kissing his ass for shelling out $800 million to give us a little wiggle room for a short time. Obviously, Yasu expects a return on his investment in TPUSA.
Why would he invest in TPUSA? USA market is hurting, overseas markets are growing.Here is my prediction. I foresee TPUSA getting sold within the next couple years. Just seems to me that by making TPUSA a separate entity from TPNA and TP global, he would have a more saleable organization and still keep the other global profit centers around the world. Cut off Mexico and Canada from TPNA to create TPUSA. This smaller company is more affordable to more buyers. Actos goes generic, TPUSA becomes what TAP was a few years ago with Prevacid going generic, and you know the rest of the story.

Is anybody else a believer in this conspiracy theory?

Nostradamus
Reply With Quote
  #13  
Old 04-16-2012, 09:06 AM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Doug Cole was a Prevacid rep for ONE YEAR before he went in house to start his Marketing career. He has no clue how to manage through this challenging time. I wish you all the best. The company has not been the same since Yasu left for Japan. It is so sad to see things come to this. Tap was the greatest company I will ever work for. To watch it go from so much promise with Prevacid and Lupron, a "strong Pipeline," to gout, Prevacid II (which I cannot believe hasn't done better...SELL IT AT $2.00 A PILL LIKE AZ DOES), and a 5th entrant CV drug. Bring back Spectracef. Bring back Naprapac. Stupid ideas like that started the doom of Takeda.
Reply With Quote
  #14  
Old 04-16-2012, 10:26 AM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Quote:
Originally Posted by Anonymous View Post
Doug Cole was a Prevacid rep for ONE YEAR before he went in house to start his Marketing career. He has no clue how to manage through this challenging time. I wish you all the best. The company has not been the same since Yasu left for Japan. It is so sad to see things come to this. Tap was the greatest company I will ever work for. To watch it go from so much promise with Prevacid and Lupron, a "strong Pipeline," to gout, Prevacid II (which I cannot believe hasn't done better...SELL IT AT $2.00 A PILL LIKE AZ DOES), and a 5th entrant CV drug. Bring back Spectracef. Bring back Naprapac. Stupid ideas like that started the doom of Takeda.
TAP had a powerhouse of leaders with Alan MacKenzie, Yasu, Art Rice, Don Patton and others. Who knows how well these leaders can do in todays market. It is a different time
Reply With Quote
  #15  
Old 04-16-2012, 08:57 PM
Anonymous
 
Posts: n/a
Lol Re: Did Yasu say...No more layoffs?

[quote=Anonymous;4331842]0nly 500 million in sales? We will do close to 2 Billion without Actos in 2013. Check your math.

Show me the money! I don't come up with 1 Billion, let alone anything close to 2 Billion?? Remember to only count what the field sales force (1,800 reps) will be selling.

Actos family = Not counting as it's gone in August.
Alogliptin = Not approved yet

Dexilant =
Amitiza =
Uloric =
Edarbi Family =

Non Field Sales Drugs (do not count):
Omontys =
Prevacid =
Rozerem =
Reply With Quote
  #16  
Old 04-16-2012, 08:58 PM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Quote:
Originally Posted by Anonymous View Post
TAP had a powerhouse of leaders with Alan MacKenzie, Yasu, Art Rice, Don Patton and others. Who knows how well these leaders can do in todays market. It is a different time
Lets be honest. Those guys did a great job launching TAP. But after Prevacid and Lupron they had no plan. they just rode those products into the ground. They didn't look ahead and our fate was sealed. Then when they took over Takeda they really had no clue what to do and now they are all gone and we are screwed.
Reply With Quote
  #17  
Old 04-16-2012, 09:27 PM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

[quote=Anonymous;4332632]
Quote:
Originally Posted by Anonymous View Post
0nly 500 million in sales? We will do close to 2 Billion without Actos in 2013. Check your math.

Show me the money! I don't come up with 1 Billion, let alone anything close to 2 Billion?? Remember to only count what the field sales force (1,800 reps) will be selling.

Actos family = Not counting as it's gone in August.
Alogliptin = Not approved yet

Dexilant =
Amitiza =
Uloric =
Edarbi Family =

Non Field Sales Drugs (do not count):
Omontys =
Prevacid =
Rozerem =
Forgot to mention Colcrys....

My guess is Dex = 150 mill, Amitiza is 120 mill, Uloric = 50 mill, Edarbi = 2 mill, and Colcrys = 400 mill.................GRAND TOTAL = 750 mill, not enough to keep 1,800 reps! We probably need 100 miilion per 100 reps - so revenue for rep sold products should be atleast 1.8 Billion

Labor costs in a typical business usually run 30% - so 1 reps total cost to Takeda is probably 250K on average with salary and all the bennys. So 1 million gross revenue per rep is a good conservative number (25% labor cost) to calculate proper headcount.
Reply With Quote
  #18  
Old 04-16-2012, 09:41 PM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Well first off your rules are wrong. Last I checked revenue is all money coming in not just a certain selected group of income earners. Obviously the field sales products will not be generating the huge sales revenue like the past. Leadership has acknowledge this and stated the plan is to bottom the next several years and regain growth as new products enter the market and others grow...something like 2017ish return to past revenue. So with that as the plan you DO INCLUDE all products knowing that they are bridging us to the future.

These are from 3rd qtr and do not include any grow factor.

Dexilant: $296 Million yr
Uloric: $160 Million yr
Edarbi/Family $4 Million yr (much higher then these #'s)
Amitiza: $232 Million yr
Colcyrs: $430 Million yr
Prevacid: $232 Million yr
Prevacid AG: 17 Million yr
Rozerem: $52 Million yr
Generics: $170 Million yr
Nesina & Oseni- ?
Omontys?
Actos 6months 1.6Billion

Total without Actos or Nesina products
$1,593,000,000

With Actos 6 months

$3,195,000,000

With Actos 6 months Branded, Nesina & Oseni, Omontys, and some growth of exisiting products?

$3.3-3.5 Billion in 2012.



[quote=Anonymous;4332632]
Quote:
Originally Posted by Anonymous View Post
0nly 500 million in sales? We will do close to 2 Billion without Actos in 2013. Check your math.

Show me the money! I don't come up with 1 Billion, let alone anything close to 2 Billion?? Remember to only count what the field sales force (1,800 reps) will be selling.

Actos family = Not counting as it's gone in August.
Alogliptin = Not approved yet

Dexilant =
Amitiza =
Uloric =
Edarbi Family =

Non Field Sales Drugs (do not count):
Omontys =
Prevacid =
Rozerem =
Reply With Quote
  #19  
Old 04-16-2012, 09:50 PM
Anonymous
 
Posts: n/a
Lol Re: Did Yasu say...No more layoffs?

Quote:
Originally Posted by Anonymous View Post
Lets be honest. Those guys did a great job launching TAP. But after Prevacid and Lupron they had no plan. they just rode those products into the ground. They didn't look ahead and our fate was sealed. Then when they took over Takeda they really had no clue what to do and now they are all gone and we are screwed.
Tap could easily have survived on Lupron, Dex, otc Prev, Uloric, and ColeCris

The Takeda Legacy Group was/is worthless

At least Cole teamed up with Goldman and
Got shit done!

I would keep the 1/10 good Tak Legacy reps
And roll with Tappers its the only way


#REALTALK
Reply With Quote
  #20  
Old 04-16-2012, 10:09 PM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Quote:
Originally Posted by Anonymous View Post
Tap could easily have survived on Lupron, Dex, otc Prev, Uloric, and ColeCris

The Takeda Legacy Group was/is worthless

At least Cole teamed up with Goldman and
Got shit done!

I would keep the 1/10 good Tak Legacy reps
And roll with Tappers its the only way


#REALTALK
Hey #REALLOSER


that worthless legacy group you keep whining about? They bought your nostalgia and they bought it because they had more money and they had more money because the reps ate your lunch every day in the field and the reps ate your lunch cause you are a dork who signs posts on an anonymous web chat board douche
Reply With Quote
  #21  
Old 04-17-2012, 08:16 AM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

[quote=Anonymous;4332720]Well first off your rules are wrong. Last I checked revenue is all money coming in not just a certain selected group of income earners. Obviously the field sales products will not be generating the huge sales revenue like the past. Leadership has acknowledge this and stated the plan is to bottom the next several years and regain growth as new products enter the market and others grow...something like 2017ish return to past revenue. So with that as the plan you DO INCLUDE all products knowing that they are bridging us to the future.

These are from 3rd qtr and do not include any grow factor.

Dexilant: $296 Million yr
Uloric: $160 Million yr
Edarbi/Family $4 Million yr (much higher then these #'s)
Amitiza: $232 Million yr
Colcyrs: $430 Million yr
Prevacid: $232 Million yr
Prevacid AG: 17 Million yr
Rozerem: $52 Million yr
Generics: $170 Million yr
Nesina & Oseni- ?
Omontys?
Actos 6months 1.6Billion

Total without Actos or Nesina products
$1,593,000,000

With Actos 6 months

$3,195,000,000

With Actos 6 months Branded, Nesina & Oseni, Omontys, and some growth of exisiting products?

$3.3-3.5 Billion in 2012.





Sales of Dexi might be $296 mill,but little profit as deals are being cut to increase MS,so practically giving away product to give appearance that it is growing on its own merit!Profitability very low!!
Reply With Quote
  #22  
Old 04-17-2012, 10:28 AM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

[quote=Anonymous;4332720]Well first off your rules are wrong. Last I checked revenue is all money coming in not just a certain selected group of income earners. Obviously the field sales products will not be generating the huge sales revenue like the past. Leadership has acknowledge this and stated the plan is to bottom the next several years and regain growth as new products enter the market and others grow...something like 2017ish return to past revenue. So with that as the plan you DO INCLUDE all products knowing that they are bridging us to the future.

I disagree. The basic rule of business requires that any cost must be fully justified, and every deal must stand on it's own merits. In other words, you only need X number of sales reps to promote X number of products. Total revenues are one thing, but if a sales force/unit of labor is not currently necessary, it will be identified as an "overage/surplus" and a justification for keeping that overage must accompany any executive business plan. They may be willing to strategically "invest" in extra field sales force headcount for a while, but at some point it has to be matched and properly right-sized to the revenue "it" and only "it" generates.

As I said earlier, It's a very good bet that we are currently Field Rep heavy and will be dealt with accordingly in due time. Bottom line takeaway: We are heavy right now, but the plan is to keep or invest in us another year or two in hopes that the revenue catches up which will justify current headcount. If I was betting in Vegas, my chips would be on the catch-up strategy won't materialize - too many headwinds. Namely Generic vs Branded.
Reply With Quote
  #23  
Old 04-17-2012, 11:22 AM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Quote:
Originally Posted by Anonymous View Post
Watched the URL webcast. Thought I heard him apologize for the January RIF, and then promptly and emphatically say....That's it, NO MORE, WE'RE DONE with layoffs.

Am I hearing things?
English very bad! He said "no more payoffs",meaning forget about a decent severance!
Reply With Quote
  #24  
Old 04-17-2012, 01:09 PM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Quote:
Originally Posted by Anonymous View Post
Lets be honest. Those guys did a great job launching TAP. But after Prevacid and Lupron they had no plan. they just rode those products into the ground. They didn't look ahead and our fate was sealed. Then when they took over Takeda they really had no clue what to do and now they are all gone and we are screwed.
Let's REALLY be honest here. Prevacid and Lupron would be great drugs even if blind monkeys sold it. There are way too many people taking credit for drugs that were successful IN SPITE of their efforts rather than BECAUSE of their efforts, as so many like to claim.

Actos is the same thing. Takeda reps were and still are a joke. Ask Lilly, Kos, Cephalon, Sucampo, etc. Why do you think lightning has never struck again? Look at all the upper management people who think they made Actos what it is? Guess what.....it's the other way around.

Get over yourselves people and pray for the REAL stars to shine.....the dumb luck of a unique molecule accidently falling into your lap.
Reply With Quote
  #25  
Old 04-17-2012, 02:05 PM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Quote:
Originally Posted by Anonymous View Post
Let's REALLY be honest here. Prevacid and Lupron would be great drugs even if blind monkeys sold it. There are way too many people taking credit for drugs that were successful IN SPITE of their efforts rather than BECAUSE of their efforts, as so many like to claim.

Actos is the same thing. Takeda reps were and still are a joke. Ask Lilly, Kos, Cephalon, Sucampo, etc. Why do you think lightning has never struck again? Look at all the upper management people who think they made Actos what it is? Guess what.....it's the other way around.

Get over yourselves people and pray for the REAL stars to shine.....the dumb luck of a unique molecule accidently falling into your lap.
You are so right. There is an old saying; "In business circles, success has many parents. Failure, however, is an orphan."
Reply With Quote
  #26  
Old 04-17-2012, 03:01 PM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Quote:
Originally Posted by Anonymous View Post
Let's REALLY be honest here. Prevacid and Lupron would be great drugs even if blind monkeys sold it. There are way too many people taking credit for drugs that were successful IN SPITE of their efforts rather than BECAUSE of their efforts, as so many like to claim.

Actos is the same thing. Takeda reps were and still are a joke. Ask Lilly, Kos, Cephalon, Sucampo, etc. Why do you think lightning has never struck again? Look at all the upper management people who think they made Actos what it is? Guess what.....it's the other way around.

Get over yourselves people and pray for the REAL stars to shine.....the dumb luck of a unique molecule accidently falling into your lap.
Can't fully agree with your post. I can completely agree with you post regarding Actos. One competitor pulled from the market and the other has a major negative lable change. As much as we tried to screw up marketing Actos, there is no way it could have not been a multi billion dollar product.

On the other hand, Prevacid was the second PPI launched and went against the power house of Merck and Astra. With 3 additional competitors on Prevacids heals, that was a drug that needed to be sold and TAP did a great job. From securing managed care contracts against major competition to feet on the street reps pulling through at the physician level. Lupron had no market and TAP created that market. They also kept over 80% share in the face of huge pricing competition from AZ for Zoladex. Prevacid and Lupron took great marketing, sales and managed care to be successful product. Actos? Well blind monkeys could have driven that product to $3 billion a year.

It is time to get rid of the Takeda Legacy dead weight and replace all possible with URL reps. Unfortunately, all we have left in managed markets RAM and NAM ranks is Takeda Legacy. That is one of the MAJOR reasons we are sucking now.

It's time to purge all Takeda Legacy from this company. I know most out there agree.
Reply With Quote
  #27  
Old 04-17-2012, 04:24 PM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Quote:
Originally Posted by Anonymous View Post
Can't fully agree with your post. I can completely agree with you post regarding Actos. One competitor pulled from the market and the other has a major negative lable change. As much as we tried to screw up marketing Actos, there is no way it could have not been a multi billion dollar product.

On the other hand, Prevacid was the second PPI launched and went against the power house of Merck and Astra. With 3 additional competitors on Prevacids heals, that was a drug that needed to be sold and TAP did a great job. From securing managed care contracts against major competition to feet on the street reps pulling through at the physician level. Lupron had no market and TAP created that market. They also kept over 80% share in the face of huge pricing competition from AZ for Zoladex. Prevacid and Lupron took great marketing, sales and managed care to be successful product. Actos? Well blind monkeys could have driven that product to $3 billion a year.

It is time to get rid of the Takeda Legacy dead weight and replace all possible with URL reps. Unfortunately, all we have left in managed markets RAM and NAM ranks is Takeda Legacy. That is one of the MAJOR reasons we are sucking now.

It's time to purge all Takeda Legacy from this company. I know most out there agree.
Typical tapper. BLINDLY loyal even with all the evidence now in plain sight after 4 years of screwing up. Its like commenting on the beautiful view while the car is going over the cliff.
Reply With Quote
  #28  
Old 04-17-2012, 05:17 PM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Quote:
Originally Posted by Anonymous View Post
Can't fully agree with your post. I can completely agree with you post regarding Actos. One competitor pulled from the market and the other has a major negative lable change. As much as we tried to screw up marketing Actos, there is no way it could have not been a multi billion dollar product.

On the other hand, Prevacid was the second PPI launched and went against the power house of Merck and Astra. With 3 additional competitors on Prevacids heals, that was a drug that needed to be sold and TAP did a great job. From securing managed care contracts against major competition to feet on the street reps pulling through at the physician level. Lupron had no market and TAP created that market. They also kept over 80% share in the face of huge pricing competition from AZ for Zoladex. Prevacid and Lupron took great marketing, sales and managed care to be successful product. Actos? Well blind monkeys could have driven that product to $3 billion a year.

It is time to get rid of the Takeda Legacy dead weight and replace all possible with URL reps. Unfortunately, all we have left in managed markets RAM and NAM ranks is Takeda Legacy. That is one of the MAJOR reasons we are sucking now.

It's time to purge all Takeda Legacy from this company. I know most out there agree.
Why don't you want to sign your posts anymore #realtalk? Rezulin was pulled from the market before Actos was even approved. How does that constitute a competitor? Do you have a clue? Avandia was a GSK breadwinner who outspent us 3 to 1. Then it gets restricted. Ask a Celebrex rep how well they did when Vioxx went down- it hardly helps. Oh and then add cancer on top of that.

"As much as we tried to screw up marketing Actos, there is no way it could have not been a multi billion dollar product." After not even getting the story straight. Are you serious??

You claim that there were three competitors at Prevacid's heels? You were in the lead and you lost the race is that what you mean? You were getting paid in the shade doing no work and then AZ came and sleighed you. The funny thing is selling a PPI is the most simple pharma sell I have done in my 11 years. I have never even reviewed a single study in the 2 years I have promoted Dex Don't get me wrong, it's a fun sell and I like it. But ask anyone how it compares to diabetes
Reply With Quote
  #29  
Old 04-17-2012, 06:36 PM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Somebody better tell that person that said we were getting over $200 million in sales from Amitiza that the drug is GONE!!!!! Sucampo is taking the drug back. Don't believe me look at their website under careers.
Reply With Quote
  #30  
Old 04-17-2012, 07:53 PM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Quote:
Originally Posted by Anonymous View Post
Somebody better tell that person that said we were getting over $200 million in sales from Amitiza that the drug is GONE!!!!! Sucampo is taking the drug back. Don't believe me look at their website under careers.
It's called planning. Just because they are posting and interviewing for 100 reps doesn't mean they have hired them. Check out the Sucampo board to see how many people that were interviewed have not heard back from the company about the next step.
It could be Sucampo is queing up candidates in the event that they do get a judgement. No judgement could mean no hiring.
Reply With Quote
  #31  
Old 04-17-2012, 09:00 PM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Quote:
Originally Posted by Anonymous View Post
It's called planning. Just because they are posting and interviewing for 100 reps doesn't mean they have hired them. Check out the Sucampo board to see how many people that were interviewed have not heard back from the company about the next step.
It could be Sucampo is queing up candidates in the event that they do get a judgement. No judgement could mean no hiring.
Ever think they may be hiring bc they are launching a new drug? Try googling Rescula.

100 new hires cannot replace a nationwide pcp/gi sales force.
Reply With Quote
  #32  
Old 04-17-2012, 10:48 PM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Takeda managed care team does suck...fact!
Reply With Quote
  #33  
Old 04-17-2012, 10:55 PM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Quote:
Originally Posted by Anonymous View Post
Why don't you want to sign your posts anymore #realtalk? Rezulin was pulled from the market before Actos was even approved. How does that constitute a competitor? Do you have a clue? Avandia was a GSK breadwinner who outspent us 3 to 1. Then it gets restricted. Ask a Celebrex rep how well they did when Vioxx went down- it hardly helps. Oh and then add cancer on top of that.

"As much as we tried to screw up marketing Actos, there is no way it could have not been a multi billion dollar product." After not even getting the story straight. Are you serious??

You claim that there were three competitors at Prevacid's heels? You were in the lead and you lost the race is that what you mean? You were getting paid in the shade doing no work and then AZ came and sleighed you. The funny thing is selling a PPI is the most simple pharma sell I have done in my 11 years. I have never even reviewed a single study in the 2 years I have promoted Dex Don't get me wrong, it's a fun sell and I like it. But ask anyone how it compares to diabetes
There are studies with Dex??????? LOL by far the easiest sell ever. T2D vs GERD???? You Tappers are pathetic. I could understand why you loved TAP so much. You dropped off samples and got paid without having to sell. And I love when they say that Actos has no competition. They truly dont understand the market and for that matter dont understand any market bc they are UPS delivery man. Actually, they are the extra worker the UPS guy hires to help during the holidays.
Reply With Quote
  #34  
Old 04-17-2012, 11:36 PM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Quote:
Originally Posted by Anonymous View Post
Why don't you want to sign your posts anymore #realtalk? Rezulin was pulled from the market before Actos was even approved. How does that constitute a competitor? Do you have a clue? Avandia was a GSK breadwinner who outspent us 3 to 1. Then it gets restricted. Ask a Celebrex rep how well they did when Vioxx went down- it hardly helps. Oh and then add cancer on top of that.

"As much as we tried to screw up marketing Actos, there is no way it could have not been a multi billion dollar product." After not even getting the story straight. Are you serious??

You claim that there were three competitors at Prevacid's heels? You were in the lead and you lost the race is that what you mean? You were getting paid in the shade doing no work and then AZ came and sleighed you. The funny thing is selling a PPI is the most simple pharma sell I have done in my 11 years. I have never even reviewed a single study in the 2 years I have promoted Dex Don't get me wrong, it's a fun sell and I like it. But ask anyone how it compares to diabetes
Almost but not quite. Rezulin was pulled nearly a year after the launch of Actos in spring of 2000. That did not make it easier for Takeda or GSK to sell TZDs since docs got nervous after Rezulin was shown to blow up the liver on a moment's notice. We split the conversions down the middle and both products kept about a 50% share until 2007 when the Nissen letter came out.

I agree with your analogy on the Cox-!! market 100%. Celebrex got cut off at the knees thanks to Vioxx and Bextra getting yanked. The drug was on track to do about $5 BILLION at peak and now does about 10% of that.

You are also correct that TAP handed over the PPI market to AZ after riding the coattails of Prilosec to the number two spot in the market. Fact is, they lost to Nexium, the AZ equivalent of Kapidex/Dexilant. Ironically, AZ continues to kick the shit out of Dex with nobody even promoting Nexium. You would think the TAP braintrust now running the show would have figured out a way to win that PPI market share. I guess that just proves that they were blessed with dumb luck they could never replicate again today.

TAP was successful because they had some great molecules and a willingness to bribe KOLs into writing Lupron and Prevacid. Nothing more. Don't believe me? Look up the article profiling Doug Durand from Business week 2002. Tap reps gave away vacations and big screen television sets to EVERY targeted specialist in their territories. What the heck, I'll just post a link to the story here:

http://www.businessweek.com/magazine...5/b3788094.htm

That's quite a proud history Tappers. You really were great sales people. Scumbags.
Reply With Quote
  #35  
Old 04-18-2012, 01:15 AM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Takeda like "Take da medicine?" or shall we say we need to takedabreak!
Reply With Quote
  #36  
Old 04-18-2012, 07:52 AM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Quote:
Originally Posted by Anonymous View Post
Almost but not quite. Rezulin was pulled nearly a year after the launch of Actos in spring of 2000. That did not make it easier for Takeda or GSK to sell TZDs since docs got nervous after Rezulin was shown to blow up the liver on a moment's notice. We split the conversions down the middle and both products kept about a 50% share until 2007 when the Nissen letter came out.

I agree with your analogy on the Cox-!! market 100%. Celebrex got cut off at the knees thanks to Vioxx and Bextra getting yanked. The drug was on track to do about $5 BILLION at peak and now does about 10% of that.

You are also correct that TAP handed over the PPI market to AZ after riding the coattails of Prilosec to the number two spot in the market. Fact is, they lost to Nexium, the AZ equivalent of Kapidex/Dexilant. Ironically, AZ continues to kick the shit out of Dex with nobody even promoting Nexium. You would think the TAP braintrust now running the show would have figured out a way to win that PPI market share. I guess that just proves that they were blessed with dumb luck they could never replicate again today.

TAP was successful because they had some great molecules and a willingness to bribe KOLs into writing Lupron and Prevacid. Nothing more. Don't believe me? Look up the article profiling Doug Durand from Business week 2002. Tap reps gave away vacations and big screen television sets to EVERY targeted specialist in their territories. What the heck, I'll just post a link to the story here:

http://www.businessweek.com/magazine...5/b3788094.htm

That's quite a proud history Tappers. You really were great sales people. Scumbags.
WOW, this is crazy......Now I know why the Tappies long for their Tappy days
Reply With Quote
  #37  
Old 04-18-2012, 09:23 AM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Lets face it. Takeda Legacy are pathetic lazy complainers. They spend more time making shit up to make themselves look good than they do working. I agree with many of the posts that our managed markets team SUCKS. Look at them, they are ALMOST ALL Takeda Legacy. In the field, all Takeda Legacy reps and managers gossip, try to make TAP legacy look bad and just make stuff up to make themselves look like they are working or know what they are doing.

Next RIF should be all Takeda Legacy peeps.
Reply With Quote
  #38  
Old 04-18-2012, 10:23 AM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Quote:
Originally Posted by Anonymous View Post
Lets face it. Takeda Legacy are pathetic lazy complainers. They spend more time making shit up to make themselves look good than they do working. I agree with many of the posts that our managed markets team SUCKS. Look at them, they are ALMOST ALL Takeda Legacy. In the field, all Takeda Legacy reps and managers gossip, try to make TAP legacy look bad and just make stuff up to make themselves look like they are working or know what they are doing.

Next RIF should be all Takeda Legacy peeps.
Yup that is so true!!!
Reply With Quote
  #39  
Old 04-18-2012, 11:59 AM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

Here's a more accurate article regarding the TAP & Douglas Durand's whistle blower suit.

http://www.forbes.com/forbes/2005/0314/090_print.html
Reply With Quote
  #40  
Old 04-18-2012, 12:08 PM
Anonymous
 
Posts: n/a
Default Re: Did Yasu say...No more layoffs?

The real issue is Tappers running this joint for 4 years and still pointing fingers and making excuses for disastrous results. Really how can anyone defend what is so obviously a group of nice people in way over their heads. this is a business-not a frat...our livelihood is dependent on these goofballs. Its time everyone woke up to that fact.
Reply With Quote
  #41  
Old 04-18-2012, 01:10 PM
Anonymous
 
Posts: n/a
Wink Re: Did Yasu say...No more layoffs?

Last I checked the Diabetes franchise
Took the bullet train straight outta dodge
Perhaps you should too!

Better yet lay across its tracks!
Reply With Quote
Reply




Thread Tools
Display Modes Rate This Thread
Rate This Thread:

Posting Rules
You may post new threads
You may post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is Off
HTML code is Off
Forum Jump


All times are GMT -4. The time now is 08:25 PM.


Powered by vBulletin® Version 3.6.11
Copyright ©2000 - 2014, Jelsoft Enterprises Ltd.